Cocrystal Pharma (COCP) Price Target Increased by 33.33% to 8.16

Cocrystal Pharma’s average one-year price target was revised up to $8.16 per share from $6.12, a 33.33% increase. The move reflects improved analyst expectations, but the article provides no underlying operational or clinical catalyst. Impact is likely limited to sentiment around the stock rather than broader market activity.

Analysis

Cocrystal Pharma’s average one-year price target was revised up to $8.16 per share from $6.12, a 33.33% increase. The move reflects improved analyst expectations, but the article provides no underlying operational or clinical catalyst. Impact is likely limited to sentiment around the stock rather than broader market activity.